If you use insulin or take diabetes synthroid and estrogen by mouth, ask your doctor if your dose needs to be changed when you start using levothyroxine. Hyperactivity in an older child can be minimized if the starting dose is one-fourth of the recommended full replacement dose, and the dose is then increased on a weekly basis by an amount equal to one-fourth the full-recommended replacement dose until the full recommended replacement dose synthroid and estrogen reached. They include the following: General fatigue, increased appetite, weight loss, heat intolerance, fever, excessive sweating; Central nervous system headache, hyperactivity, nervousness, anxiety, irritability, emotional lability, insomnia; Musculoskeletal tremors, muscle weakness; Cardiovascular palpitations, tachycardia, arrhythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest; Respiratory dyspnea; Gastrointestinal diarrhea, vomiting, abdominal cramps and elevations in liver function tests; Dermatologic hair loss, flushing; Endocrine decreased bone mineral density; Reproductive menstrual irregularities, impaired fertility. Every effort has been made to ensure that the information provided by Cerner Multum, Inc. Check blood sugar levels closely.
taking synthroid while pregnant
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. The fetus, neonate, elderly and euthyroid patients with underlying thyroid disease (e.g., Hashimoto's thyroiditis or with Grave's disease previously treated with radioiodine or surgery) are among those individuals who are particularly susceptible to iodine-induced hypothyroidism. What happens if I miss a dose? Take the missed dose as soon as you remember. --If you miss a dose... If the patient is a child or if you cannot swallow the tablet whole, you may crush the correct dose of the medicine. You should not use this medication if you have had a heart attack, a thyroid disorder called thyrotoxicosis, or an adrenal gland problem that is not controlled by treatment. Regardless of the indication for use, careful dosage titration is necessary to avoid the consequences of over- or under-treatment. Sympathomimetics Concurrent use may increase the effects of sympathomimetics or thyroid hormone. Contact your doctor if hair loss is severe or persistent. 1 synthroid and estrogen YELLOW NO. However, estrogen use appeared to negate the adverse effects of thyroid hormone on bone mineral density. If you suspect a massive overdose, seek emergency medical attention immediately. If you suspect a massive overdose, seek emergency medical attention immediately. Proper storage of Synthroid: Store Synthroid between 68 and 77 degrees F (20 and 25 degrees C). 1 Aluminum Lake 137 FD&C Blue No. 6 Product Characteristics Color ORANGE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;25 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-4341-13 100 TABLET In 1 BOTTLE None 2 0074-4341-19 1000 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-4552 Route of Administration synthroid and estrogen DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 50 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC Product Characteristics Color WHITE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;50 Contains Packaging # synthroid and estrogen Package Description Multilevel Packaging 1 0074-4552-13 100 TABLET In 1 BOTTLE None 2 0074-4552-19 1000 TABLET In 1 synthroid and estrogen None 3 0074-4552-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a BLISTER PACK 3 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-4552-11) 4 0074-4552-71 28 TABLET In 1 BOX None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product synthroid and estrogen (Source) 0074-5182 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength synthroid and estrogen LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 75 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C RED NO. TSH may not normalize due to a resetting of the pituitary-thyroid feedback threshold as a result of in utero hypothyroidism. The presence of concomitant medical conditions should be considered in certain clinical circumstances and, if present, appropriately treated (see PRECAUTIONS ).
It is very important to take Synthroid with a full glass (8 ounces) of water. Newborns The recommended starting dose of levothyroxine sodium in newborn infants is 10-15 mcg/kg/day . Your doctor may need to change your dose of Synthroid. Package Label.Principal Display Panel NDC 0074–6624–71 Synthroid® (levothyroxine Sodium Tablets, USP) www.Synthroid.com This package for households without young children Rx Only Package Label.Principal Display Panel NDC synthroid and estrogen 100 Tab Abbo-Pac® Abbo-Pac Unit Dose Synthroid® (levothyroxine Sodium Tablets, USP) 100 mcg (0.1 mg) Rx Only Tamper Evident: Do not accept if seal over bottle opening is broken or synthroid and estrogen Acquired Hypothyroidism in Pediatric Patients The patient should be monitored closely to avoid undertreatment and overtreatment. --Storage instructions... Failure to do so may precipitate an acute adrenal crisis when thyroid hormone therapy is initiated, due to increased metabolic clearance of glucocorticoids by thyroid hormone. Therefore, the dose of Synthroid used for TSH suppression should be individualized based on the specific disease and the patient being treated. Larger doses may produce serious or even life synthroid and estrogen manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. Check with your health care provider before you start, stop, or change the dose of any medicine.